Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients

Transplantation Proceedings

Volumn 34, Issue 6, 2002, Pages 2081-2082

  Colak, T ^a   Karakayali, H ^a   Yagmurdur, M C ^a   Moray, G ^a  

^a NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLOSPORIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TSUKUBAENOLIDE;

ADULT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RECIPIENT; SIDE EFFECT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLESTEROL; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; HYPERLIPIDEMIAS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; TACROLIMUS; TRIGLYCERIDES;

EID: 0036755329     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)02859-2     Document Type: Article

References (10)

1. Friemann S., Feuring E., Ernst W. Transplant Proc. 30:1998;1240.
2. Copley J.B., Staffeld C., Hansen J.A., et al. Transplant Proc. 30:1998;1254.
3. Manu M., Tanabe K., Ishykawa N., et al. Transplant Proc. 32:2000;1736.
4. Mariana S., Markell S., Arnetti V., Danovitch G., et al. J Am Soc Nephrol. 4:1994;S37.
5. McCauley J., Shapiro R., Jordan M.L., et al. Transplant Proc. 33:2001;1698.
6. Kahnle M., Zimmermann U., Lutkes P., et al. Transplant Proc. 13:2000;S345.
7. Vela C.G., Cristol J.P., Descomps B., et al. Transplant Proc. 32:2000;398.
8. Burke GW, Ciancio G, Alejandro R, et al: 30:514, 1998.
9. Satterthwaite R., Aswad S., Shiban H., et al. Transplantation. 65:1998;446.
10. Vanrenterghem F.C.h. Curr Opin Nephrology Hyperten. 8:1999;669.